JPMorgan maintains Chugai Pharmaceutical at 'overweight' with a price target of JPY5000.00

  • Investing.com
JPMorgan maintains Chugai Pharmaceutical at 'overweight' with a price target of JPY5000.00

An analyst from JPMorgan maintained Chugai Pharmaceutical (TYO: 4519 ) at 'overweight' with a price target of JPY5000.00 from a prior price target of %currency%%price%.

Prior to this rating, Chugai Pharmaceutical had 7 buy ratings, 7 hold ratings, and 0 sell ratings.

For consensus analyst estimates and price targets on Chugai Pharmaceutical, click here. For more news on Chugai Pharmaceutical, click here.

Chugai Pharmaceutical's stock price closed at $4.0. They are down -99.91% in the last month and up 25.3% in the last 12 months.

According to Investing Pro, Chugai Pharmaceutical's fair value is $4.6K, an upside of 2.6%. Chugai Pharmaceutical's fair value comes with a low degree of uncertainty, according to InvestingPro.

Check out Chugai Pharmaceutical's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles